Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
16.55
+0.52 (3.24%)
Oct 26, 2026, 12:18 PM EDT - Market open
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $242.92 million as of October 26, 2026. It is the 19,688th most valuable company in the world and the 3,428th biggest in the United States. Its market cap has increased by 78.40% in one year.
Market Cap
242.92M
Enterprise Value
234.05M
1-Year Change
78.40%
Global Rank
Country Rank
#3,428 United States
Category
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $242.92M, an increase of 253.66%. That is a compound annual growth rate of 23.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 242.92M | -16.54% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 248.47M |
| Larimar Therapeutics | 245.30M |
| Vanda Pharmaceuticals | 242.46M |
| Immuneering | 241.32M |
| AC Immune | 240.61M |
| Palisade Bio | 231.78M |
| Lyell Immunopharma | 230.10M |
| InflaRx | 229.89M |